Holen Sie sich die Stockscreener-App
89.24
1.16%
-1.045
Handel nachbörslich:
89.24
Schlusskurs vom Vortag:
$90.28
Offen:
$90.32
24-Stunden-Volumen:
354.25K
Relative Volume:
0.38
Marktkapitalisierung:
$2.66B
Einnahmen:
$442.68M
Nettoeinkommen (Verlust:
$-77.81M
KGV:
-33.44
EPS:
-2.6684
Netto-Cashflow:
$-28.65M
1W Leistung:
+8.10%
1M Leistung:
+47.41%
6M Leistung:
+11.96%
1J Leistung:
-30.92%
1-Tages-Spanne:
$88.55
$91.78
1-Wochen-Bereich:
$80.76
$91.78
52-Wochen-Spanne:
$32.21
$170.87
Genedx Holdings Corp Stock (WGS) Company Profile
Firmenname
Genedx Holdings Corp
Sektor
Branche
Telefon
888-729-1206
Adresse
333 LUDLOW STREET, STAMFORD
Compare WGS vs TMO, DHR, NTRA, A, IQV
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
89.24 | 2.46B | 442.68M | -77.81M | -28.65M | -2.6684 |
TMO
Thermo Fisher Scientific Inc
|
630.70 | 232.03B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
215.68 | 151.78B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
338.70 | 46.82B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
157.69 | 44.14B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
262.38 | 42.15B | 16.63B | 1.39B | 2.12B | 8.0674 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-09 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-07-09 | Eingeleitet | Piper Sandler | Overweight |
| 2025-05-15 | Eingeleitet | Guggenheim | Buy |
| 2025-05-09 | Hochstufung | Jefferies | Hold → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-07-10 | Eingeleitet | Craig Hallum | Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
Alle ansehen
Genedx Holdings Corp Aktie (WGS) Neueste Nachrichten
A Look at GeneDx Holdings Corp (WGS) After 5.5% Gain -- GF Value $73.66 vs Price $87.06 - GuruFocus
GeneDx Holdings Corp. $WGS Shares Purchased by Bank of America Corp DE - MarketBeat
Can GENEDX HOLDINGS (WGS) Run Higher on Rising Earnings Estimates? - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Encourages GeneDx Holdings Cor - The National Law Review
Is GeneDx’s Direct-to-Family Exome Platform Reshaping The Investment Case For GeneDx Holdings (WGS)? - Sahm
GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2026-08-18 | GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:WGS | Press Release - Stockhouse
GeneDx: Why I Think The Worst Is Behind The Business (NASDAQ:WGS) - Seeking Alpha
WGS DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Inv - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Investors to Connect - ACCESS Newswire
WGS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce - The National Law Review
GeneDx Holdings (WGS) Slips 1.35% to $78.08, Holds Midpoint of Trading RangeCall Flow Alert - Vinanet
GeneDx Holdings (WGS) Slips 1.35% as Shares Hold Between Key Support and ResistanceDelta Hedging - Vinanet
GeneDx Holdings (WGS), Why Is This Fresh Development Drawing Attention? - Sahm
Precision Trading with Genedx Holdings Corp. (WGS) Risk Zones - Stock Traders Daily
The Manufacturers Life Insurance Company Sells 12,820 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Stockholders to Connect - ACCESS Newswire
Sei Investments Co. Trims Stock Position in GeneDx Holdings Corp. $WGS - MarketBeat
Is GeneDx Holdings Corp (WGS) Overvalued After 5.1% Rally? GF Va - GuruFocus
GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Goldman Sachs Group (WGS) discloses 5.8% beneficial stake in GeneDx Class A - Stock Titan
GeneDx at Canaccord Genuity conference: volume rises, collections lag - Investing.com
GeneDx Holdings (WGS) Is Up 14.8% After Loss-Making Q2, New Capital Raise And Guidance Reaffirmation - simplywall.st
GeneDx launches online exome testing for pediatric patients - Investing.com
GeneDx Lets Families Start Children’s Exome Testing Online - Stock Titan
GeneDx Holdings Corp. (WGS) Stock Analysis: A Genomics Pioneer with 10.28% Upside Potential - DirectorsTalk Interviews
Assenagon Asset Management S.A. Acquires 208,305 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
GENEDX HOLDINGS CORP. : PIPER SANDLER RAISES TARGET PRICE TO $95 FROM $63 - Moomoo
GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026 - The National Law Review
GeneDx Holdings Corp. $WGS Shares Acquired by Dimensional Fund Advisors LP - MarketBeat
GeneDx (NASDAQ:WGS) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
GeneDx Holdings (WGS) Is Up 18.4% After Reaffirming 2026 Outlook And Raising Equity From Blackstone - Yahoo Finance
WGS CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds GeneDx (WGS - The National Law Review
GeneDx Holdings (WGS): ARK Investment and Cathie Wood report 5.33% ownership - Stock Titan
GeneDx Holdings Corp (WGS) Stock News Today - TradingKey
WGS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Annou - The National Law Review
GeneDx to Participate in Upcoming Investor Conferences - marketscreener.com
GeneDx Holdings Corp. (NASDAQ:WGS) Analysts Are Pretty Bullish On The Stock After Recent Results - simplywall.st
GeneDx Holdings Corp. Earnings Call Highlights Risks - The Globe and Mail
GeneDx Holdings Corp. (WGS) Options Chain - Yahoo! Finance Canada
Cathie Wood’s ARK sells Palantir stock, buys GeneDx Holdings - Investing.com
Cathie Wood’s ARK sells Palantir stock, buys GeneDx Holdings By Investing.com - Investing.com Nigeria
GeneDx Holdings Corp. Stock 12‑Month Price Target Raised to $85.89, Implies 27% Upside - TradingView
Canaccord Genuity Group Issues Positive Forecast for GeneDx (NASDAQ:WGS) Stock Price - MarketBeat
GeneDx Holdings Corp. Q2 2026 Earnings Call Summary - Yahoo Finance
GeneDx Holdings Corp. (WGS) Stock Analysis: Strong Buy Ratings and 20% Potential Upside - DirectorsTalk Interviews
GeneDx Holdings Corp (WGS) (Q2 2026) Earnings Call Highlights: Record Volume and Early ... By GuruFocus - Investing.com Canada
GeneDx Holdings (WGS) Is Up 9.7% After Beating Q2 Estimates And Reaffirming 2026 OutlookHas The Bull Case Changed? - simplywall.st
GeneDx Q2 Adjusted Earnings Fall, Revenue Rises; Issues Q3 Outlook - Yahoo Finance
GeneDx Holdings Corp. (WGS) Releases Q2 2026 Earnings: Revenue Beats Estimates but Losses Persist - Quiver Quantitative
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026 - Morningstar
Finanzdaten der Genedx Holdings Corp-Aktie (WGS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Genedx Holdings Corp-Aktie (WGS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| RUCH JOSHUA | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
3,576 |
0 |
33,299 |
| PFENNIGER RICHARD C JR | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
3,576 |
0 |
45,082 |
| Meister Keith A. | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
3,576 |
0 |
23,705 |
| Leproust Emily M. | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
3,576 |
0 |
24,852 |
| Casdin Eli | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
3,576 |
0 |
24,093 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Jun 16 '26 |
Option Exercise |
0.00 |
7,197 |
0 |
43,683 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Jun 16 '26 |
Sale |
60.77 |
3,729 |
226,597 |
39,954 |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Jun 16 '26 |
Option Exercise |
0.00 |
18,750 |
0 |
114,873 |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Jun 16 '26 |
Sale |
60.77 |
10,501 |
638,104 |
104,372 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Jun 09 '26 |
Option Exercise |
0.00 |
2,462 |
0 |
37,752 |
0.24%
1.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):